Prescription errors can have devastating consequences, particularly when they involve compounded medications that do not undergo the same rigorous testing as FDA-approved drugs. A recent JAMA study highlights growing concerns about compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which have surged in popularity due to their effectiveness in treating diabetes and promoting weight loss. While compounding pharmacies play an important role in customizing medications for individual needs, errors in this process can result in serious health risks.
Understanding the risks associated with compounded drugs is essential for Maryland patients who rely on pharmacies to provide safe medications. When a pharmacy makes an error with a compounded medication, patients may suffer severe side effects, incorrect dosages, or exposure to harmful contaminants. Legal options exist for those harmed by prescription mistakes, but proving liability requires an experienced attorney who understands the regulations surrounding Maryland pharmacies and compounded drugs.
Understanding Compounded Medications and Their Purpose